Norwegian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Japanese Journal of Nephrology 2009

[Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis].

Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
Koblingen er lagret på utklippstavlen
Nobuhiro Sasaki
Shinichi Takeda
Takako Saito
Yasuhiro Ando
Eiji Kusano

Nøkkelord

Abstrakt

OBJECTIVE

Metabolic syndrome (Met S) is one of the risk factors of atherosclerotic vascular diseases related to visceral fat accumulation. However, it is well known that morbidity and mortality of hemodialysis (HD) patients are associated with malnutrition and emaciation rather than obesity, representing "reverse epidemiology". The risk of visceral fat accumulation or Met S in HD patients remains unclear. Therefore, we evaluated atherosclerosis and Met S in HD patients using various markers of obesity by means of bioelectrical impedance analysis (BIA) and brachial-ankle PWV(baPWV).

METHODS

The subjects comprised 52 patients who were undergoing maintenance dialysis. In addition to a general physical examination and routine blood tests, immunoreactive insulin (IRI), homeostasis model assessment for insulin resistance (HOMA-R), serum adiponectin (ADPN) and C-reactive protein (CRP)were measured before dialysis. Furthermore, we measured various body fluid components, such as the ratio of extracellular water to total body water (ECW/TBW), body fat mass (BFM), percent body fat(PBF) and visceral fat accumulation (BIA-VFA), using a body composition analyzer (InBody S20)and baPWV as a marker of atherosclerosis.

RESULTS

There was no significant difference between HD patients with and without Met S for baPWV. baPWV was positively correlated with age, systolic BP and ECW/TBW, and negatively correlated with serum albumin level, BMI and serum ADPN. However, no significant correlations were observed between baPWV and the durations of HD, Ca x P product, BIA-VFA, PBF, HOMA-R and CRP. The serum ADPN level was significantly lower in Met S than in non-Met S. In addition, the ADPN level was positively correlated with HDL-cholesterol, and negatively correlated with TG, HbA1c, CRP and various markers of obesity (Waist, BIA-VFA, BFM and PBF). In a multiple regression analysis for baPWV, the ECW/TBW ratio and serum ADPN level, as well as age and systolic BP, were independent predictors for the enhancement of baPWV in HD patients.

CONCLUSIONS

The present study demonstrated that the ECW/TBW ratio and low serum ADPN level, but not Met S or obesity, could be risk factors for the acceleration of atherosclerosis in HD patients. In addition, the results showed that the relationship between ADPN,as an anti-atherosclerotic factor, and body fat or lipid metabolism were also maintained in HD patients.

Bli med på
facebooksiden vår

Den mest komplette databasen med medisinske urter støttet av vitenskap

  • Fungerer på 55 språk
  • Urtekurer støttet av vitenskap
  • Urtegjenkjenning etter bilde
  • Interaktivt GPS-kart - merk urter på stedet (kommer snart)
  • Les vitenskapelige publikasjoner relatert til søket ditt
  • Søk medisinske urter etter deres effekter
  • Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter

Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot.
* All informasjon er basert på publisert vitenskapelig forskning

Google Play badgeApp Store badge